The Journal of Organic Chemistry
Note
7.72 (1H, d, J = 7.6 Hz), 7.68 (1H, d, J = 7.6 Hz), 7.50−7.57 (2H, m),
7.32−7.42 (3H, m), 7.24 (1H, dt, J = 2.4, 7.8 Hz), 7.16 (1H, t, J = 7.6
Hz), 7.09 (1H, d, J = 6.8 Hz), 7.00−7.05 (2H, m), 1.90 (3H, s); 13C
NMR (CDCl3) δ: 166.6, 141.0, 138.3, 135.9, 135.5, 133.0, 131.3,
131.0, 130.3, 130.2, 129.7, 129.0, 128.9, 128.4, 127.8, 126.6, 125.1,
123.1, 122.6, 17.3; MS (m/z) 366 (MH+, 79Br), 368 (MH+, 81Br);
HRMS. Calcd for C20H1779BrNO (MH+) 366.04935. Found:
366.04628. Anal. Calcd for C20H16BrNO: C, 65.59; H, 4.40; N,
3.82. Found: C, 65.33; H, 4.37; N, 3.78.
(MNa+); HRMS. Calcd for C23H15NONa (MNa+) 344.10513. Found:
344.10539.
5-(2-Ethylphenyl)phenanthridin-6(5H)-one (2d). 2d was pre-
pared from 1d (74 mg, 0.2 mmol) in accordance with the procedure
described in the preparation of 2a. Purification of the residue by
column chromatography (hexane/AcOEt = 5) gave 2d (40 mg, 68%,
68% ee). The enantiomers of 2d were separated by HPLC using a
CHIRALCEL OD-3 column [25 cm × 0.46 cm i.d.; 17% i-PrOH in
hexane; flow rate, 1.5 mL/min; (+)-2d (major); tR = 8.7 min, (−)-2d
(minor); tR = 12.5 min]. 2d: colorless liquid; [α]D = +55.1 (c = 0.38,
5-(2-iso-Propylphenyl)phenanthridin-6(5H)-one (2a). Under
an Ar atmosphere, to the suspension of Pd(OAc)2 (3.4 mg, 0.015
mmol) and (R)-DTBM-SEGPHOS (26.5 mg, 0.0225 mmol) in
toluene-1,4-dioxane (1.35−0.15 mL) were added 1a (118 mg, 0.30
mmol) in toluene-1,4-dioxane (1.35 mL-0.15 mL) and subsequently
K3PO4 (127 mg, 0.6 mmol). After being stirred for 10 min at rt, the
reaction mixture was stirred for 17 h at 80 °C. The mixture was poured
into 2% HCl solution and extracted with AcOEt. The AcOEt extracts
were washed with brine, dried over MgSO4, and evaporated to dryness.
Purification of the residue by column chromatography (hexane/AcOEt
= 10) gave 2a (91 mg, 96%, 77% ee). The enantiomers of 2a were
separated by HPLC using a CHIRALCEL OD-3 column [25 cm ×
0.46 cm i.d.; 17% i-PrOH in hexane; flow rate, 1.5 mL/min; (+)-2a
(major); tR = 4.6 min, (−)-2a (minor); tR = 17.1 min]. 2a: white solid;
mp 57−59 °C (77% ee); [α]D = +49.8 (c = 0.40, CHCl3, 80% ee); IR
1
CHCl3, 70% ee); IR (neat) 1653 cm−1; H NMR (CDCl3) δ: 8.57
(1H, d, J = 8.4 Hz), 8.34 (1H, d, J = 8.4 Hz), 8.29−8.32 (1H, m), 7.81
(1H, dt, J = 1.2, 7.2, Hz), 7.61 (1H, t, J = 7.6 Hz), 7.46−7.52 (2H, m),
7.41 (1H, dt, J = 2.0, 7.2 Hz), 7.26−7.30 (2H, m), 7.19 (1H, d, J = 7.2
Hz), 6.59−6.63 (1H, m), 2.42 (1H, qd, J = 7.6, 15.2 Hz), 2.32 (1H,
qd, J = 7.6, 15.2 Hz), 1.07 (3H, t, J = 7.6 Hz); 13C NMR (CDCl3) δ:
161.3, 141.9, 138.9, 136.6, 134.1, 132.8, 129.5, 129.2, 129.1, 128.0,
127.7, 125.9, 123.0, 122.6, 121.8, 119.0, 116.7, 23.6, 13.6; MS (m/z)
322 (MNa+); HRMS. Calcd for C21H17NONa (MNa+) 322.12078.
Found: 322.12061.
5-(2-Methylphenyl)phenanthridin-6(5H)-one (2e). 2e was
prepared from 1e (72 mg, 0.2 mmol) in accordance with the
procedure described in the preparation of 2a. Purification of the
residue by column chromatography (hexane/AcOEt = 5) gave 2e (42
mg, 74%, 42% ee). The enantiomers of 2e were separated by HPLC
using a CHIRALCEL OD-3 column [25 cm × 0.46 cm i.d.; 9% i-
PrOH in hexane; flow rate, 1.0 mL/min; (+)-2e (major enantiomer);
tR = 25.7 min, (−)-2e (minor enantiomer); tR = 30.4 min]. 2e: white
solid; mp 102−104 °C (42% ee); [α]D = +26.3 (c = 0.26, CHCl3, 42%
ee); IR (neat) 1651 cm−1; 1H NMR (CDCl3) δ: 8.58 (1H, dd, J = 1.2,
7.6 Hz), 8.34 (1H, d, J = 8.4 Hz), 8.29−8.32 (1H, m), 7.81 (1H, dt, J =
1.2, 7.8 Hz), 7.61 (1H, dt, J = 1.0, 7.8 Hz), 7.38−7.47 (3H, m), 7.26−
7.31 (2H, m), 7.21 (1H, dd, J = 2.4, 6.4 Hz), 6.60 (1H, m), 2.05 (3H,
s); 13C NMR (CDCl3) δ: 161.0, 138.4, 137.1, 136.5, 134.1, 132.8,
131.5, 129.3, 129.0, 128.9, 128.0, 127.7, 125.9, 123.1, 122.7, 121.8,
119.0, 116.3, 17.4; MS (m/z) 308 (MNa+); HRMS. Calcd for
C20H15NONa (MNa+) 308.10513. Found: 308.10504.
1
(neat) 1657 cm−1; H NMR (CDCl3) δ: 8.56 (1H, dd, J = 0.8, 7.6
Hz), 8.34 (1H, d, J = 8.0 Hz), 8.30 (1H, m), 7.81 (1H, ddd, J = 2.0,
7.6, 8.8 Hz), 7.61 (1H, ddd, J = 1.2, 7.6, 8.8 Hz), 7.55 (1H, dd, J = 1.6,
8.0 Hz), 7.50 (1H, dt, J = 1.2, 7.6 Hz), 7.38 (1H, dt, J = 1.6, 7.6 Hz),
7.24−7.31 (2H, m), 7.15 (1H, dd, J = 1.2, 7.8 Hz), 6.57−6.62 (1H,
m), 2.64 (1H, sept, J = 6.8 Hz), 1.16 (3H, d, J = 6.8 Hz), 1.01 (3H, d, J
= 6.8 Hz); 13C NMR (CDCl3) δ: 161.4, 146.7, 139.0, 135.6, 134.0,
132.7, 129.4, 129.1 129.0, 128.8, 128.0, 127.5, 127.2, 125.8, 122.9,
122.6, 121.7, 118.8, 116.8, 28.0, 23.8, 23.4; MS (m/z) 336 (MNa+);
HRMS. Calcd for C22H19NONa (MNa+) 336.13643. Found:
336.13928.
5-(2-tert-Butylphenyl)phenanthridin-6(5H)-one (2b). 2b was
prepared from 1b (119 mg, 0.3 mmol) in accordance with the
procedure described in the preparation of 2a. Purification of the
residue by column chromatography (hexane/AcOEt = 10) gave 2b
(92.6 mg, 97%, 73% ee). The enantiomers of 2b were separated by
HPLC using a CHIRALCEL OD-3 column [25 cm × 0.46 cm i.d.; 9%
i-PrOH in hexane; flow rate, 1.5 mL/min; (+)-2b (major); tR = 6.9
min, (−)-2b (minor); tR = 11.3 min]. 2b: white solid; mp 61−63 °C
(>99% ee); [α]D = +97.7 (c = 0.40, CHCl3, 70% ee); IR (neat) 1655
Optical Purification through SDE by MPLC of 2a. Medium-
pressure liquid chromatography (MPLC, eluent: hexane/AcOEt = 30)
of 2a (82% ee, 42 mg) was performed on a 25 × 4 cm i.d. prepacked
column (silica gel, 10 μm) with a UV detector. The eluted substrate 2a
was collected in two fractions across the boundary point, and >99% ee
(21 mg) and 56% ee (14 mg) of 2a were obtained from less polar and
more polar fractions, respectively.
1
cm−1; H NMR (CDCl3) δ: 8.57 (1H, dd, J = 0.8, 7.6 Hz), 8.33 (1H,
Optical Purification through SDE by MPLC of 2b. Medium-
pressure liquid chromatography (MPLC, eluent: hexane/AcOEt = 30)
of 2b (73% ee, 90 mg) was performed on a 25 × 4 cm i.d. prepacked
column (silica gel, 10 μm) with a UV detector. The eluted substrate 2b
was collected in two fractions across the boundary point, and >99% ee
(27 mg) and 62% ee (59 mg) of 2b were obtained from less polar and
more polar fractions, respectively.
d, J = 8.0 Hz), 8.29 (1H, dd, J = 1.6, 7.6 Hz), 7.80 (1H, t, J = 7.2 Hz),
7.72 (1H, dd, J = 1.4, 8.0 Hz), 7.60 (1H, t, J = 7.6 Hz), 7.47 (1H, dt, J
= 1.2, 8.0 Hz), 7.37 (1H, dt, J = 1.2, 7.4 Hz), 7.24−7.32 (2H, m), 7.02
(1H, dd, J = 1.4, 7.8 Hz), 6.57 (1H, dd, J = 1.2, 8.0 Hz), 1.16 (9H, s);
13C NMR (CDCl3) δ: 162.4, 147.5, 140.0, 135.7, 134.0, 132.8, 131.3,
130.0, 129.1, 129.0, 128.9, 128.0, 128.0, 126.0, 123.0, 122.5, 121.8,
119.0, 118.0, 36.1, 31.6; MS (m/z) 350 (MNa+); HRMS. Calcd for
C23H21NONa (MNa+) 350.15208. Found: 350.15242.
2-Bromo-5-(2-(tert-butyl)phenyl)phenanthridin-6(5H)-one
(3b). To the solution of 2b (>99% ee, 44 mg, 0.134 mmol) in DMF
(2.0 mL) was added N-bromosuccinimide (48 mg, 0.272 mmol). After
being stirred for 24 h at 50 °C, the mixture was poured into 2% HCl
solution and extracted with AcOEt. The AcOEt extracts were washed
with brine, dried over MgSO4, and evaporated to dryness. Purification
of the residue by column chromatography (hexane/AcOEt = 15) gave
3b (50.4 mg, 89%). 3b: white solid; mp 159−161 °C; [α]D = +108.7
5-(Naphthalen-1-yl)phenanthridin-6(5H)-one (2c). 2c was
prepared from 1c (80 mg, 0.2 mmol) in accordance with the
procedure described in the preparation of 2a. Purification of the
residue by column chromatography (hexane/AcOEt = 5) gave 2c (60
mg, 94%, 70% ee). The enantiomers of 2c were separated by HPLC
using a CHIRALCEL OD-3 column [25 cm × 0.46 cm i.d.; 33% i-
PrOH in hexane; flow rate, 1.0 mL/min; (+)-2c (major); tR = 8.0 min,
(−)-2c (minor); tR = 14.9 min]. 2c: white solid; mp 229−231 °C
(70% ee); [α]D = +131.1 (c = 0.40, CHCl3, 70% ee); IR (neat) 1653
1
(c = 0.40, CHCl3); IR (neat) 1659 cm−1; H NMR (CDCl3) δ: 8.56
(1H, d, J = 8.0 Hz), 8.38 (1H, d, J = 2.0 Hz), 8.24 (1H, d, J = 8.0 Hz),
7.81 (1H, dt, J = 1.2, 7.8 Hz), 7.71 (1H, dd, J = 1.4, 8.2 Hz), 7.63 (1H,
t, J = 7.6 Hz), 7.47 (1H, dt, J = 1.2, 8.0 Hz), 7.34−7.39 (2H, m), 6.99
(1H, dd, J = 1.2, 7.6 Hz), 6.45 (1H, d, J = 8.4 Hz), 1.16 (9H, s); 13C
NMR (CDCl3) δ: 162.1, 147.6, 139.0, 135.3, 133.0, 132.7, 131.7,
131.2, 130.1, 129.2, 129.2, 128.8, 128.1, 126.1, 125.7, 121.9, 120.7,
119.6, 115.7, 36.1, 31.6; MS (m/z) 428 (MNa+, 79Br), 430 (MNa+,
81Br); HRMS. Calcd for C23H2079BrNONa (MNa+) 428.06260.
Found: 428.05948.
1
cm−1; H NMR (CDCl3) δ: 8.63 (1H, dd, J = 1.2, 8.0 Hz), 8.42 (1H,
d, J = 8.4 Hz), 8.37 (1H, dd, J = 1.2, 8.0 Hz), 8.07 (1H, d, J = 8.4 Hz),
8.01 (1H, d, J = 8.0 Hz), 7.87 (1H, dt, J = 1.2, 7.8 Hz), 7.64−7.72 (2H,
m), 7.50−7.55 (2H, m), 7.46 (1H, d, J = 8.4 Hz), 7.38 (1H, t, J = 7.6
Hz), 7.29 (1H, t, J = 7.2 Hz), 7.21 (1H, dt, J = 1.2, 8.0 Hz), 6.54 (1H,
d, J = 8.4 Hz); 13C NMR (CDCl3) δ: 161.7, 139.1, 134.9, 134.8, 134.2,
133.0, 130.2, 129.4, 129.3, 129.2, 128.6, 128.1, 127.4, 127.1, 126.6,
126.1, 125.8, 123.0, 122.7, 122.4, 121.8, 119.0, 117.2; MS (m/z) 344
E
J. Org. Chem. XXXX, XXX, XXX−XXX